Medicinal Product Shortages – update – 29 June 2022

Notice type: Advisory

Date: 29/06/2022

 

Further Information:

The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Arava 10mg Film Coated Tablets - EU/1/99/118/003
  • Amoxicillin 250mg/5ml Powder for Oral Suspension - PA0126/282/004
  • Amoxicillin 500mg Capsules - PA0126/282/002
  • Calvepen 333mg Tablets - PA0126/137/001
  • Calvepen 666mg Tablets - PA0126/137/002
  • Creon 10000 Gastro-resistant Capsules - PA2010/008/001
  • Flucloxacillin 1g Powder for Solution for Injection or Infusion - PA0281/228/003
  • Fucibet 20mg/g + 1mg/g Cream - PA0046/040/001
  • Gemcitabine Actavis 40mg/ml Concentrate for Solution for Infusion (25mg vial) - PA1380/182/001
  • Lenzetto 1.53mg/spray Transdermal Spray - PA1330/017/001
  • Lyclear 5% w/w Dermal Cream - PA1077/066/001
  • Tamoxifen 20mg Tablets - PA0577/207/001
  • Tavanic 5mg/ml Solution for Infusion - PA0540/077/001

 

The following shortages have been resolved and supply has resumed to the Irish market:

  • Cernevit, Powder for Solution for Injection or Infusion - PA2299/019/001
  • Crinone 8% w/w Progesterone Gel - PPA1463/112/001
  • Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion- PA0822/121/001
  • EpiPen Junior 150mcg Solution for Injection in Pre Filled Pen - PA2010/062/001
  • Microlite 100mcg/20mcg Tablets - PA1410/007/001
  • MacroBID 100mg Prolonged Release Capsules - PA1142/033/001
  • Naropin 7.5mg/ml Solution for Injection - PA1691/026/002
  • Neoclarityn 0.5mg/ml Oral Solution (150ml) - EU/1/00/161/067
  • Paricalcitol 5mcg/ml Solution for Injection - PA0281/163/001
  • RoActemra 162mg Pre Filled Pen - EU/1/08/492/009
  • TicoVac Junior 0.25ml Suspension for Injection in a Pre Filled Syringe - PA0822/184/002

 

Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 




« Back